Risk Adjustment Vs Population Health
A precise buyer's guide for choosing between these two intelligence assets. Both solve real operational problems — but for different buyers, different workflows, and different financial objectives. Use this comparison to identify which dataset fits your specific need, then go directly to the purchase or sample page.
How to Think About This Comparison
Medicare Advantage Risk Adjustment Dataset (MARAD)
Choose MARAD when the primary objective is MA risk adjustment revenue — RAF score improvement, HCC coding completeness, and RADV compliance. MARAD is revenue-focused: its output is higher CMS payments through more accurate risk representation.
Population Health Risk Dataset (PHRD)
Choose PHRD when the primary objective is member health outcome improvement and care management efficiency — identifying high-risk members, targeting interventions, and reducing avoidable utilization. PHRD is cost and quality-focused: its output is better care management targeting and lower total cost of care.
Recommended Dataset Purchase Paths
Medicare Advantage Risk Adjustment Dataset (MARAD)
Use MARAD when the CFO's question is: 'How do we capture more RAF revenue from our enrolled population?' Best for VP Risk Adjustment, VP MA, and Medical Directors.
Population Health Risk Dataset (PHRD)
Use PHRD when the CMO's question is: 'How do we identify the right members for care management to reduce avoidable admissions and improve outcomes?' Best for VP Population Health, VP Care Management, and Quality leaders.
Buyer Decision Matrix
| Dataset | When It Fits | Next Step |
|---|---|---|
| Medicare Advantage Risk Adjustment Dataset (MARAD) | Revenue-side MA optimization: HCC capture, RAF score benchmarking, prospective condition coding. | Purchase Page |
| Population Health Risk Dataset (PHRD) | Cost-side population health optimization: high-risk member identification, intervention prioritization, avoidable utilization reduction. | Purchase Page |
Commercial Recommendation
Leading MA plans use both: MARAD to maximize risk adjustment revenue from the population's actual clinical complexity, PHRD to reduce the clinical events that drive utilization costs. Together they optimize both the revenue and cost sides of the MA financial equation.